Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1834013 | 0.87 | PAOX (0.43) | CHRM1CYP2C19MEN1GLAKMT2A | |
| SCHEMBL1831104 | 0.84 | PAOX (0.45) | CHRM1CYP2C19PAOXALDH1A1POLB | |
| SCHEMBL21320206 | 0.84 | PAOX (0.44) | CYP2C19MEN1GLAKMT2APAOX | |
| SCHEMBL22305801 | 0.84 | PAOX (0.44) | CYP2C19MEN1GLAKMT2APAOX | |
| SCHEMBL27324068 | 0.82 | CYP2C19 (0.35) | CYP2C19MEN1GLAKMT2ACYP1A2 | |
| SCHEMBL10614292 | 0.81 | PAOX (0.42) | CYP2C19PAOXTSHRALDH1A1 | |
| SCHEMBL22794786 | 0.81 | SAT1 (0.31) | MEN1KMT2A | |
| SCHEMBL1832776 | 0.80 | PAOX (0.40) | CHRM1CYP2C19MEN1KMT2APAOX | |
| SCHEMBL1831795 | 0.80 | CYP2C19 (0.33) | CYP2C19MEN1GLAKMT2ACYP1A2 | |
| SCHEMBL6448030 | 0.79 | PAOX (0.30) | CYP2C19MEN1GLAKMT2APAOX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2323145-A1 | Electrolytic solution for electrolytic capacitor and electrolytic capacitor as well as method for preparing an organic onium tetrafluoroaluminate | MITSUBISHI CHEMICAL CORPORATION (JP) | 2011-05-18 | — | — | EP | claimed |
| CN-100466122-C | Electrolytic solution for electrolytic capacitor, and method for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEM CORP (JP) | 2009-03-04 | — | — | CN | claimed |
| US-7397651-B2 | Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEMICAL CORPORATION (JP) | 2008-07-08 | — | — | US | claimed |
| US-20070188977-A1 | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-08-16 | — | — | US | claimed |
| US-20060007629-A1 | Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-01-12 | — | — | US | claimed |
| CN-1708817-A | Electrolytic solution for electrolytic capacitor, and method for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEM CORP (JP) | 2005-12-14 | — | — | CN | claimed |
| EP-1564768-A1 | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM | Mitsubishi Chemical Corporation (JP) | 2005-08-17 | — | — | EP | claimed |
| WO-2024108198-A2 | METHODS OF TREATING OBESITY WITH AN MC4R AGONIST | RHYTHM PHARMACEUTICALS, INC. (US) | 2024-05-23 | — | — | WO | disclosed |
| EP-2843673-B1 | ELECTROLYTIC SOLUTION FOR ALUMINUM ELECTROLYTIC CAPACITOR, AND ALUMINUM ELECTROLYTIC CAPACITOR USING SAME | SANYO CHEMICAL IND LTD (JP) | 2019-01-16 | — | — | EP | disclosed |
| EP-3357916-A1 | BENZAMIDE DERIVATIVE | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. (CN) | 2018-08-08 | — | — | EP | disclosed |
| US-20170362346-A1 | METHODS AND SYSTEMS FOR POLYMER PRECIPITATION AND GENERATION OF PARTICLES | CERULEAN PHARMA INC (US) | 2017-12-21 | — | — | US | disclosed |
| US-9691552-B2 | Electrolytic solution for aluminum electrolytic capacitor, and aluminum electrolytic capacitor using same | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2017-06-27 | — | — | US | disclosed |
| WO-2016044641-A2 | CARM1 INHIBITORS AND USES THEREOF | Epizyme, Inc. (US) | 2016-03-24 | — | — | WO | disclosed |
| US-20070188977-A1 | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20070188979-A1 | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-7227738-B2 | Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-06-05 | — | — | US | disclosed |
| WO-2007015812-A2 | HIV REVERSE TRANSCRIPTASE INHIBITORS | MERCK & CO., INC. (US) | 2007-02-08 | — | — | WO | disclosed |
| US-20060007629-A1 | Electrolyte for electrolytic capacitor, electrolytic capacitor and process for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEMICAL CORPORATION (JP) | 2006-01-12 | — | — | US | disclosed |
| CN-1708817-A | Electrolytic solution for electrolytic capacitor, and method for producing tetrafluoroaluminate salt of organic onium | MITSUBISHI CHEM CORP (JP) | 2005-12-14 | — | — | CN | disclosed |
| EP-1564768-A1 | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM | Mitsubishi Chemical Corporation (JP) | 2005-08-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070188977-A1 | ELECTROLYTE FOR ELECTROLYTIC CAPACITOR, ELECTROLYTIC CAPACITOR AND PROCESS FOR PRODUCING TETRAFLUOROALUMINATE SALT OF ORGANIC ONIUM | AFF2, CACNA2D2, AFF4 | CHRM1 1644/4885CYP2C19 4595/4885MEN1 1119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.